D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
GE Vernova
GEV
|
+$601M |
| 2 |
Walt Disney
DIS
|
+$510M |
| 3 |
Palantir
PLTR
|
+$502M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$490M |
| 5 |
TSMC
TSM
|
+$396M |
Top Sells
| 1 |
Boeing
BA
|
+$967M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$567M |
| 4 |
Eli Lilly
LLY
|
+$551M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| 1 | Technology | 20.32% |
| 2 | Healthcare | 13% |
| 3 | Consumer Discretionary | 12.32% |
| 4 | Financials | 8.62% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Theravance Biopharma
TBPH
$690M
| $8.22M | 0.01% |
920,302
+86,359
| +10% | +$771K |
|
1002
Jazz Pharmaceuticals
JAZZ
$7.79B
| $8.22M | 0.01% |
66,191
-235,918
| -78% | -$29.3M |
|
1003
Rayonier
RYN
$4.13B
| $8.21M | 0.01% |
294,323
+179,710
| +157% | +$5.01M |
|
|
ACCD
1004
DELISTED
Accolade, Inc. Common Stock
ACCD
| $8.2M | 0.01% |
1,175,449
-1,105,334
| -48% | -$7.72M |
|
1005
RenaissanceRe
RNR
$11.5B
| $8.14M | 0.01% |
+33,918
| New | +$8.14M |
|
1006
JELD-WEN Holding
JELD
$566M
| $8.13M | 0.01% |
1,361,821
+411,604
| +43% | +$2.46M |
|
1007
Central Garden & Pet Class A
CENTA
$2.09B
| $8.12M | 0.01% |
247,958
+72,033
| +41% | +$2.36M |
|
1008
Otter Tail
OTTR
$3.52B
| $8.11M | 0.01% |
100,876
+18,561
| +23% | +$1.49M |
|
1009
Azenta
AZTA
$1.43B
| $8.1M | 0.01% |
233,853
-66,931
| -22% | -$2.32M |
|
1010
MGIC Investment
MTG
$6.67B
| $8.1M | 0.01% |
326,716
+298,317
| +1,050% | +$7.39M |
|
1011
Healthcare Services Group
HCSG
$1.2B
| $8.08M | 0.01% |
801,201
-100,141
| -11% | -$1.01M |
|
1012
Green Plains
GPRE
$641M
| $8.06M | 0.01% |
1,661,383
+863,316
| +108% | +$4.19M |
|
1013
Brookfield Asset Management
BAM
$91.5B
| $8.04M | 0.01% |
+165,886
| New | +$8.04M |
|
1014
First Bancorp
FBP
$3.54B
| $8.04M | 0.01% |
419,227
+251,820
| +150% | +$4.83M |
|
1015
Invesco
IVZ
$10.1B
| $8.03M | 0.01% |
529,538
+437,343
| +474% | +$6.63M |
|
1016
Occidental Petroleum
OXY
$45.3B
| $8.02M | 0.01% |
162,424
-327,336
| -67% | -$16.2M |
|
1017
Regions Financial
RF
$24.1B
| $7.98M | 0.01% |
367,280
+67,867
| +23% | +$1.47M |
|
1018
Alpha Metallurgical Resources
AMR
$1.86B
| $7.97M | 0.01% |
63,618
+37,438
| +143% | +$4.69M |
|
1019
Hudson Technologies
HDSN
$450M
| $7.97M | 0.01% |
1,291,225
-54,328
| -4% | -$335K |
|
1020
Kornit Digital
KRNT
$667M
| $7.96M | 0.01% |
417,371
-45,578
| -10% | -$870K |
|
1021
Enhabit
EHAB
$411M
| $7.94M | 0.01% |
903,205
-101,010
| -10% | -$888K |
|
1022
Amdocs
DOX
$9.39B
| $7.89M | 0.01% |
86,279
+5,122
| +6% | +$469K |
|
1023
EchoStar
SATS
$22.2B
| $7.89M | 0.01% |
308,252
-392,868
| -56% | -$10M |
|
1024
Viking Therapeutics
VKTX
$2.89B
| $7.88M | 0.01% |
326,294
+224,051
| +219% | +$5.41M |
|
1025
Raymond James Financial
RJF
$34.1B
| $7.87M | 0.01% |
56,639
-168,632
| -75% | -$23.4M |
|